Distal apolipoprotein C-III regulatory elements F to J act as a general modular enhancer for proximal promoters that contain hormone response elements: Synergism between hepatic nuclear factor-4 molecules bound to the proximal promoter and distal enhancer sites

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 1, 1997, Pages 222-232

  Kardassis, Dimitris ^a   Tzameli, Iphigenia ^b,c   Hadzopoulou Cladaras, Margarita ^b,c   Talianidis, Iannis ^a   Zannis, Vassilis ^a,b,c  

^a INSTITUTE OF MOLECULAR BIOLOGY AND BIOTECHNOLOGY   (Greece)

^b Ctr for Adv Biomedical Research   (United States)

^c University Medical Center   (Greece)

Author keywords

apoA I gene regulation; apoC III enhancer; hepatic and intestinal expression; hepatic nuclear factor 4 (HNF 4); transcriptional synergism

Indexed keywords

APOLIPOPROTEIN C3; NUCLEAR FACTOR;

ARTICLE; BINDING SITE; ENHANCER REGION; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM;

EID: 0031037635     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.1.222     Document Type: Article

References (23)

1. Ogami K, Hadzopoulou-Cladaras M, Cladaras C, Zannis VI. Promoter elements required for hepatic and intestinal transcription of the human apoCIII gene. J Biol Chem. 1990;265:9808-9815.
2. Papazafiri P, Ogami K, Ramji DP, Nicosia A, Monad P, Cladaras C, Zannis VI. Promoter elements and factors involved in hepatic transcription of the human apoA-I gene: positive and negative regulators bind to overlapping sites. J Biol Chem. 1991;266:5790-5797.
3. Widom RL, Ladias JAA, Kouidou S, Karathanasis SK. Synergistic interactions between transcription factors control expression of the apolipoprotein A-I gene in liver cells. Mol Cell Biol. 1991;11:677-687.
4. Ktistaki E, Lacorte JM, Katrakili N, Zannis VI, Talianidis I. Transcriptional regulation of the apolipoprotein A-IV gene involves synergism between a proximal hormone response element and a distant enhancer located in the upstream promoter region of the apolipoprotein CIII gene. Nucl Acids Res. 1994;22:4689-4696.
5. Talianidis I, Tambakaki A, Toursounova J, Zannis VI. Complex interactions between SP1 bound to multiple distal regulatory sites and HNF-4 bound to the proximal promoter leads to the transcriptional activation of the liver-specific human apoCIII gene. Biochemistry. 1995;34:10298-10309.
6. Zannis VI, Tzameli I. Binding specificity and modulation of the apoA-I promoter activity by homo- and heterodimers of nuclear receptors. J Biol Chem. 1996;271:8402-8415.
7. Cladaras C, Ogami K, Kardassis D, Hadzopoulou-Cladaras M, Zannis VI. Recognition of proximal human apoCIII promoter by NFY* type, C/EBP and a family of heat stable activities. Circulation. 1991;84(suppl II):II-109. Abstract.
8. Bisaha JG, Simon TC, Gordon JL, Breslow JL. Characterization of an enhancer element in the human apolipoprotein CIII gene that regulates human apolipoprotein A-I gene expression in the intestinal epithelium. J Biol Chem. 1995;270:19979-19988.
9. Walsh A, Azrolan N, Wang K, Marcigliano A, O'Connell A, Breslow JL. Intestinal expression of the human apoA-I gene is controlled by a DNA region 3′ to the gene in the promoter of the adjacent convergently transcribed apoCIII gene. J Lipid Res. 1993;34:617-623.
10. de Silva HV, Lauer SJ, Wang J, Simonet WS, Weisgraber KH, Mahley RW, Taylor JM. Overexpression of human apolipoprotein CIII in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E. J Biol Chem. 1994;269:2324-2335.
11. Lauer SJ, Simonet WS, Bucay N, de Silva HV, Taylor JM. Tissue-specific expression of the human apolipoprotein A-IV gene in transgenic mice. Circulation. 1991;84:1390.
12. Zannis VI, Cole SF, Jackson C, Kurnit DM, Karathanasis SK. Distribution of apoA-I, apoCII, apoCIII and apoE mRNA in human tissues: time dependent induction of apoE mRNA by cultures of human monocyte-macrophages. Biochemistry. 1985;24:4450-4455.
13. Karathanasis SK, Yunis I, Zannis VI. Structure, evolution and tissue-specific synthesis of human apolipoprotein A-IV. Biochemistry. 1986;25:3962-3970.
14. Castelli WP, Doyle JT, Gordon T, Haames CG, Hjortland MC, Hulley SB, Kagan A, Zukel WJ. HDL cholesterol and other lipids in coronary artery disease: the Cooperative Lipoprotein Phenotyping Study. Circulation. 1977;55:767-772.
15. Heiss G, Tyroler HA. Proceedings of a Workshop on Apolipoprotein Quantification. Bethesda, Md: National Institutes of Health; 1982: 7-24. US Dept of Health and Human Services publication NIH 83-1266.
16. Rubin EM. Krauss RM, Spangler EA. Verstuyft JG, Clift SM. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein A-I. Nature. 1991;353:265-267.
17. Ito Y, Azrolan N, O'Connell A, Walsh A, Breslow JL. Hypertriglyceridemia as a result of human apoCIII gene expression in transgenic mice. Science. 1990;249:790-793.
18. Kardassis D, Zannis VI, Cladaras C. Organization of the regulatory elements and nuclear activities participating in the transcriptional activation of the human apoB gene. J Biol Chem. 1991;267:2622-2632.
19. Ladias JAA, Hadzopoulou-Cladaras M, Kardassis D, Cardot P, Cheng J, Zannis VI, Cladaras C. Transcriptional regulation of human apolipoprotein genes apoB, apoCIII and apoA-II by members of the steroid hormone receptor superfamily HNF-4, ARP-1, EAR-2 and EAR-3. J Biol Chem. 1992;267:15849-15860.
20. Edlund T, Walker MD, Barr PJ, Rutter WJ. Cell-specific expression of the rat insulin gene: evidence for role of two distinct 5′ flanking elements. Science. 1985;230:912-916.
21. Graham FL, van der Eb AJ. Transformation of rat cells by DNA of human adenovirus 5. Virology. 1973;52:456-467.
22. Gorman CM, Moffat LF, Howard BH. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol. 1982;2:1044-1051.
23. Lavrentiadou S, Hadzopoulou-Cladaras M, Ladias J, Cladaras C, Zannis VI. Modulation of the apoCIII promoter activity by heterodimers of ligand dependent nuclear receptors RXRa-RARa, RXRotT3Rβ and RXRα-PPARα. Circulation. 1995;92:291.